$2.33T
Total marketcap
$101.58B
Total volume
BTC 50.04%     ETH 15.40%
Dominance

Iovance Biotherapeutics, Inc. 0JDK.L Stock

12.35 USD {{ price }} -2.755901% {{change_pct}}%
Exchange
LSE
Market Cap
16.63M USD
LOW - HIGH [24H]
0.0000 - 0.0000 USD
VOLUME [24H]
112 USD
{{ volume }}
P/E Ratio
0
Earnings per share
-2.3 USD

Iovance Biotherapeutics, Inc. Price Chart

Iovance Biotherapeutics, Inc. 0JDK.L Financial and Trading Overview

Iovance Biotherapeutics, Inc. stock price 12.35 USD
Previous Close 8.6 USD
Open 0 USD
Bid 0 USD x 0
Ask 0 USD x 0
Day's Range 0 - 0 USD
52 Week Range 0 - 13.2 USD
Volume 1.9K USD
Avg. Volume 8.37K USD
Market Cap 11.82M USD
Beta (5Y Monthly) 0.180633
PE Ratio (TTM) N/A
EPS (TTM) -2.3 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

0JDK.L Valuation Measures

Enterprise Value 1.38B USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 2.952557
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -3.383

Trading Information

Iovance Biotherapeutics, Inc. Stock Price History

Beta (5Y Monthly) 0.180633
52-Week Change -2.98%
S&P500 52-Week Change 20.43%
52 Week High 13.2 USD
52 Week Low 0 USD
50-Day Moving Average 7.09 USD
200-Day Moving Average 8.2 USD

0JDK.L Share Statistics

Avg. Volume (3 month) 8.37K USD
Avg. Daily Volume (10-Days) 12.58K USD
Shares Outstanding 123.17M
Float 178.24M
Short Ratio N/A
% Held by Insiders 0.36%
% Held by Institutions 89.98%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio N/A
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -34.24%
Return on Equity (ttm) -67.54%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA -407744000 USD
Net Income Avi to Common (ttm) -411656000 USD
Diluted EPS (ttm) -2.3
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 626.29M USD
Total Cash Per Share (mrq) 2.79 USD
Total Debt (mrq) 83.23M USD
Total Debt/Equity (mrq) 12.48 USD
Current Ratio (mrq) 7.308
Book Value Per Share (mrq) 2.972

Cash Flow Statement

Operating Cash Flow (ttm) -318769984 USD
Levered Free Cash Flow (ttm) -175051120 USD

Profile of Iovance Biotherapeutics, Inc.

Country United Kingdom
State CA
City San Carlos
Address 825 Industrial Road
ZIP 94070
Phone 650 260 7120
Website https://www.iovance.com
Industry
Sector(s)
Full Time Employees 503

Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. The company's lead product candidate is lifileucel that is in Phase II clinical trial for the treatment of metastatic melanoma and cervical cancer. It also develops LN-145 for the treatment of metastatic non-small cell lung cancer; IOV-4001 for the treatment of melanoma non-small cell lung cancer; IOV-2001; and IOV-3001. Iovance Biotherapeutics, Inc. has collaborations and licensing agreements with H. Lee Moffitt Cancer Center; M.D. Anderson Cancer Center; Ohio State University; Centre hospitalier de l'Université de Montreal; Cellectis S.A.; Novartis Pharma AG; Melanoma Institute Australia; and Beth-Israel Deaconess Medical Center. The company was formerly known as Lion Biotechnologies, Inc. and changed its name to Iovance Biotherapeutics, Inc. in June 2017. Iovance Biotherapeutics, Inc. was incorporated in 2007 and is headquartered in San Carlos, California.

Q&A For Iovance Biotherapeutics, Inc. Stock

What is a current 0JDK.L stock price?

Iovance Biotherapeutics, Inc. 0JDK.L stock price today per share is 12.35 USD.

How to purchase Iovance Biotherapeutics, Inc. stock?

You can buy 0JDK.L shares on the LSE exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Iovance Biotherapeutics, Inc.?

The stock symbol or ticker of Iovance Biotherapeutics, Inc. is 0JDK.L.

How many shares does Iovance Biotherapeutics, Inc. have in circulation?

The max supply of Iovance Biotherapeutics, Inc. shares is 1.35M.

What is Iovance Biotherapeutics, Inc. Price to Earnings Ratio (PE Ratio)?

Iovance Biotherapeutics, Inc. PE Ratio is now.

What was Iovance Biotherapeutics, Inc. earnings per share over the trailing 12 months (TTM)?

Iovance Biotherapeutics, Inc. EPS is -2.3 USD over the trailing 12 months.